Stockscreener 앱 받기
16.05
0.94%
0.15
Tenax Therapeutics Inc 주식(TENX)의 최신 뉴스
The Technical Signals Behind (TENX) That Institutions Follow - Stock Traders Daily
Investment Review: Can Tenax Therapeutics Inc stock outperform in 2025 bull marketPortfolio Growth Summary & Low Drawdown Investment Strategies - Bộ Nội Vụ
Published on: 2026-01-14 00:08:43 - Bộ Nội Vụ
Tenax Therapeutics (NASDAQ:TENX) Share Price Passes Above Two Hundred Day Moving AverageHere's What Happened - MarketBeat
Tenax Therapeutics (NASDAQ:TENX) Is In A Good Position To Deliver On Growth Plans - Sahm
Guggenheim doubles Tenax (TENX) PT, names stock top pick - MSN
Tenax Therapeutics Stock: A Speculative Buy (NASDAQ:TENX) - Seeking Alpha
How Tenax Therapeutics Inc. stock reacts to oil prices2025 Trading Recap & Real-Time Stock Entry Alerts - Улправда
Is Tenax Therapeutics Inc. stock cheap at current valuationJuly 2025 Selloffs & Daily Profit Maximizing Tips - Улправда
Why Tenax Therapeutics Inc. stock is considered a top pickJuly 2025 Big Picture & AI Forecasted Stock Moves - ulpravda.ru
Guggenheim Doubles Tenax (TENX) PT, Names Stock Top Pick - Finviz
Will Tenax Therapeutics Inc. stock see insider buyingRisk Management & Low Drawdown Trading Techniques - Улправда
Earnings Beat: Is Tenax Therapeutics Inc. stock overvalued by current metrics2025 Support & Resistance & Risk Managed Investment Signals - Улправда
Is Tenax Therapeutics Inc. stock near bottom after declineWeekly Trend Report & Low Volatility Stock Suggestions - Улправда
What is the fair value of Tenax Therapeutics Inc. stock nowEarnings Performance Report & Real-Time Buy Signal Notifications - Улправда
Precision Trading with Tenax Therapeutics Inc. (TENX) Risk Zones - Stock Traders Daily
Tenax Therapeutics: How Lower Variance In Phase 3 Has "Loaded The Dice" For An Asymmetric Repricing - Seeking Alpha
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Tenax Therapeutics (NASDAQ:TENX) Stock Price Crosses Above 200 Day Moving AverageHere's Why - MarketBeat
Tenax Therapeutics Inc. (TENX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
How Tenax Therapeutics Inc. (TENX) Affects Rotational Strategy Timing - Stock Traders Daily
Tenax Therapeutics (NASDAQ:TENX) Stock Crosses Above 200-Day Moving AverageHere's What Happened - MarketBeat
Growth Value: Will Tenax Therapeutics Inc stock see insider buyingGold Moves & Low Risk Growth Stock Ideas - Bộ Nội Vụ
Tenax Therapeutics (TENX) Price Target Increased by 12.22% to 25.76 - Nasdaq
Is Tenax Therapeutics Inc. stock overvalued by current metricsJuly 2025 Spike Watch & Fast Exit and Entry Strategy Plans - DonanımHaber
Roth MKM Reaffirms Their Buy Rating on Tenax Therapeutics (TENX) - The Globe and Mail
Is Tenax Therapeutics Inc. stock supported by strong cash flowsMarket Movers & Low Drawdown Investment Ideas - DonanımHaber
Tenax Therapeutics (NASDAQ:TENX) Stock Crosses Above 200 Day Moving Average – What’s Next? - Defense World
Can Tenax Therapeutics Inc. stock beat market expectations this quarter2025 Technical Patterns & Safe Capital Growth Stock Tips - Улправда
Tenax Therapeutics (NASDAQ:TENX) Stock Crosses Above 200 Day Moving AverageWhat's Next? - MarketBeat
Guggenheim Maintains Tenax Therapeutics (TENX) Buy Recommendation - Nasdaq
Tenax Therapeutics’ phase 3 LEVEL study confirms enrollment target By Investing.com - Investing.com Canada
[8-K] TENAX THERAPEUTICS, INC. Reports Material Event | TENX SEC FilingForm 8-K - Stock Titan
Tenax Therapeutics (TENX) Updates on Clinical Trials and New Ini - GuruFocus
Tenax Therapeutics’ phase 3 LEVEL study confirms enrollment target - Investing.com
Tenax Therapeutics level trial on track to complete enrollment in H1 2026 - marketscreener.com
Tenax Therapeutics Confirms Enrollment Target for LEVEL Study; Initiates LEVEL-2 Phase 3 Study for TNX-103 - Quiver Quantitative
Tenax Therapeutics Level Trial On Track To Complete Enrollment In H1 2026 - TradingView — Track All Markets
Tenax Therapeutics Announces Result of Prespecifed Blinded Sample Size Assessment - The Manila Times
Heart failure drug trials expand as Tenax starts second Phase 3 study - Stock Titan
Tenax Therapeutics stock price target raised to $25 from $14 at Guggenheim - Investing.com Canada
Tenax Therapeutics (TENX): Analyst Raises Target Price to $25 | - GuruFocus
Growth Report: Is YETI stock recession proof2025 Buyback Activity & Safe Entry Zone Tips - moha.gov.vn
Discipline and Rules-Based Execution in TENX Response - Stock Traders Daily
What analysts say about Tenax Therapeutics Inc stockCovered Call Writing & Build Winning Strategies With Zero Cost - earlytimes.in
JANUS HENDERSON GROUP PLC Acquires Additional Shares in Tenax Therapeutics Inc - GuruFocus
Tenax Therapeutics (NASDAQ:TENX) Insider Stuart Rich Buys 2,500 Shares - MarketBeat
Tenax Therapeutics director Rich Stuart buys $50,792 in stock By Investing.com - Investing.com South Africa
Tenax Therapeutics director Rich Stuart buys $50,792 in stock - Investing.com
Officer/Dir Rich Buys 5,000 ($50.8K) Of Tenax Therapeutics Inc [TENX] - TradingView — Track All Markets
TENAX Therapeutics CMO Stuart Rich Acquires 5,000 Shares - TradingView — Track All Markets
Tenax Therapeutics (NASDAQ:TENX) Insider Stuart Rich Buys 1,500 Shares - MarketBeat
4.73%
0.92%
자본화:
|
볼륨(24시간):